Histopathological evaluation of the effectiveness of oral Eppikajutsuto treatment for lymphatic malformation

Lymphatic malformation (LM) is a congenital disease caused by lymphatic vessel malformation. Although standard therapies for LMs are sclerotherapy and/or surgical excision, a new therapy using Japanese herbal medicine Eppikajutsuto (TJ-28) has been recently reported as clinically effective. We aimed...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pediatric surgery 2021-09, Vol.56 (9), p.1668-1672
Main Authors: Matsudera, Shotaro, Sato-Yazawa, Hanako, Terada, Misao, Yamaguchi, Takeshi, Tani, Yukiko, Watanabe, Shun, Kashiwagi, Korehito, Ishii, Jun, Ito, Yoshifumi, Ogino, Kei, Okamoto, Kentaro, Nakajima, Masanobu, Morita, Shinji, Yamaguchi, Satoru, Kuroda, Hajime, Tsuchioka, Takashi, Kojima, Kazuyuki, Yazawa, Takuya
Format: Article
Language:English
Subjects:
Eppikajutsuto
Japanese herbal medicine
Lymphatic malformation
Model mouse
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lymphatic malformation (LM) is a congenital disease caused by lymphatic vessel malformation. Although standard therapies for LMs are sclerotherapy and/or surgical excision, a new therapy using Japanese herbal medicine Eppikajutsuto (TJ-28) has been recently reported as clinically effective. We aimed to experimentally confirm the therapeutic effectiveness of TJ-28 for LMs. LM lesions were generated in the mesentery and peritoneum of mice by intraperitoneal injection of Freund's incomplete adjuvant. Mice with LMs were treated by gavage or dietary administration of TJ-28 for 2 months. Formalin-fixed paraffin-embedded tissue sections of mesentery and peritoneum tissues were histologically and immunohistochemically examined by focusing on lymph nodes and perinodal lymph vessels. Multiple Freund's incomplete adjuvant-associated foreign-body granulomas were formed in the mesentery and peritoneum, resulting in congestion of lymph fluid and dilatation of lymph vessels. The numbers and sizes of lymph nodes were not significantly different between TJ-28-treated and control groups. However, the luminal areas of lymphatic vessels were reduced significantly in the TJ-28 treatment group by both gavage and dietary administrations. TJ-28 conspicuously reduced congestion of lymph fluid. This is the first histopathological evaluation of LM model mice to study the effectiveness of oral TJ-28 treatment.
ISSN:0022-3468
1531-5037
DOI:10.1016/j.jpedsurg.2020.09.007